Boscà , A.; Montalvá, E.M.; Vila, M.; Lladó, L.; López, V.; Gastaca, M.; Tomé, S.; Ramia, J.M.; Nuño, J.; Rotellar, F.;
et al. Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors? J. Clin. Med. 2026, 15, 938.
https://doi.org/10.3390/jcm15030938
AMA Style
Boscà A, Montalvá EM, Vila M, Lladó L, López V, Gastaca M, Tomé S, Ramia JM, Nuño J, Rotellar F,
et al. Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors? Journal of Clinical Medicine. 2026; 15(3):938.
https://doi.org/10.3390/jcm15030938
Chicago/Turabian Style
Boscà , Andrea, Eva M. Montalvá, Marina Vila, Laura Lladó, VÃctor López, Mikel Gastaca, Santiago Tomé, José M. Ramia, Javier Nuño, Fernando Rotellar,
and et al. 2026. "Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors?" Journal of Clinical Medicine 15, no. 3: 938.
https://doi.org/10.3390/jcm15030938
APA Style
Boscà , A., Montalvá, E. M., Vila, M., Lladó, L., López, V., Gastaca, M., Tomé, S., Ramia, J. M., Nuño, J., Rotellar, F., Pérez, M., Caso, Ó., Achalandabaso, M. M., Jaén, I., GarcÃa, C., RamÃrez, P., & López-Andújar, R.
(2026). Should We Continue Liver Transplantation in Spain for Hepatic Metastases from Neuroendocrine Tumors? Journal of Clinical Medicine, 15(3), 938.
https://doi.org/10.3390/jcm15030938
